STOCKHOLDERS’ DEFICIENCY AND MEZZANINE EQUITY (Details Narrative) - USD ($)			3 Months Ended						12 Months Ended
	Sep. 19, 2023	Dec. 21, 2021	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Mar. 31, 2022	Feb. 02, 2016
Common stock shares authorized			125,000,000		125,000,000				125,000,000		125,000,000
Common stock, par value			$ 0.001		$ 0.001				$ 0.001		$ 0.001
Preferred stock, shares authorized			10,000,000		10,000,000				10,000,000		10,000,000
Preferred stock convertible conversion price			$ 0.001		$ 0.001				$ 0.001		$ 0.001
Common stock, shares issued			9,353,768		8,508,052				9,353,768		8,508,052
Common stock, other shares, outstanding			160,672		244,458				160,672		244,458
Debt instrument redemption price percentage									110.00%
Issuance of preferred shares, net									$ 2,825,000
Debt conversion description											The redemption price was determined in accordance to the Series B note agreement, where the Company has an option to redeem the note at 115% of its principal value instead of converting the note upon receipt of a conversion notice. The difference between the redemption cash payment and the book value of the note redeemed, including the derivative liability associated to the note
Conversion of common shares									$ (371,634)
Accrued dividends liability				$ 16,789						$ 16,789
Stock issued during period share conversion of convertible securities									36,897
Gross proceeds from issuance of common stock									$ 123,347
Proceeds from Issuance of Common Stock									$ 119,285
Placement fee percentage									3.00%
Issuance of warrants		$ 198,713
Common shares for services received							3,796	695
Common shares for services received, value							$ 30,287	$ 7,500
Stock issued during period value new issues									$ 119,285
Common shares in lieu of interest payment, value											221,396
Common shares for services received, value									$ 116,127		150,418
Stock issued during period value warrants exercised											$ 29,774
Outstanding common stock shares to be issued			344,276		3,955				344,276		3,955
Derivative liabilities non current			$ 1,435,668		$ 759,065				$ 1,435,668		$ 759,065
Fair Value Adjustment of Warrants		$ 1,042,149
Warrants for promissory notes			57,536						57,536
Weighted average grant date exercise price			$ 2.78						$ 2.78
Stock-based compensation									$ 1,025,930		$ 647,631
2016 Equity Incentive Plan [Member]
Share based payment award number of shares authorized													1,241,422
Stock options granted									7,210		298,343
Weighted average grant date exercise price			$ 2.774		$ 6.817				$ 2.774		$ 6.817
Stock-based compensation									$ 1,025,930		$ 647,631
2023 Equity Incentive Plan [Member]
Aggregate shares					5,000,000						5,000,000
Issuance of Common Shares [Member]
Number shares removed previously to be issued								6,683
Convertible Promissory Notes [Member]
Stock issued during period share conversion of convertible securities						39,815	19,612	67,406
Debts instrument settlement amount						$ 207,002	$ 135,274	$ 406,117
Convertible notes payable						153,600	100,000	302,000
Carrying amount of conversion and redemption						53,402	35,274	104,118
Debt instrument fair value						211,602	175,295	457,025
Loss on conversion of convertible promissory notes						$ 4,600	40,020	50,908
Stock issued during period shares new issues					372
Stock issued during period value new issues					$ 1
Additional paid in capital common stock					$ 2						$ 2
General and Administrative Expense [Member]
Common shares for services received						17,544			92,125
Issuance of warrants						$ 112,631			$ 100,755
Selling, General and Administrative Expenses [Member]
Warrants and rights outstanding							$ 77,332	77,414
Maximum [Member]
Weighted average grant date exercise price					$ 13.62						$ 13.62
Minimum [Member]
Weighted average grant date exercise price					$ 2.7						$ 2.7
Minimum [Member] | Issuance of Common Shares [Member]
Cancellation of to be issued shares								$ 42,500
Shares to be Issued [Member]
Shares outstanding			344,276		3,955				344,276		3,955	20,638
Number of shares convertible securities									320,321
Converted issued shares			320,321
Shares, Issued					(16,683)						(16,683)
Common shares for services received									20,000
Stock issued during period shares warrants exercised											(16,683)
Stock issued during period value new issues
Common shares in lieu of interest payment, value
Conversion of preferred shares into common shares, shares									320,321
Conversion shares			25						25
Conversion of preferred shares into common shares									$ 228,786
Common shares for services received, value									$ 15,280
Stock issued during period shares issued					16,683						16,683
Stock issued during period value warrants exercised											$ 77,300
Outstanding common stock shares to be issued					23,723						23,723
Common Stock [Member]
Shares outstanding			9,514,440		8,752,510				9,514,440		8,752,510	8,546,261
Number of shares convertible securities				612,062					612,062		126,833
Conversion of common shares			$ 142							$ 228,727
Fair value of derivative liabilities			$ 75,523	$ 119,359
Shares, Issued			20,846						20,846
Common shares for services received									92,125		22,035
Stock issued during period shares warrants exercised											11,966
Stock issued during period shares new issues									36,897
Stock issued during period value new issues									$ 37
Common shares in lieu of interest payment											45,043
Common shares in lieu of interest payment, value											$ 45
Common shares for services received, value									$ 92		22
Stock issued during period shares issued			(20,846)						(20,846)
Stock issued during period value warrants exercised											(12)
Warrant [Member]
Stock issued during period shares warrants exercised								1,966
Stock issued during period value warrants exercise								$ 12,500
Warrants for promissory notes						51,101
Additional Paid-in Capital [Member]
Stock issued during period value new issues									$ 119,248
Common shares in lieu of interest payment, value											221,351
Common shares for services received, value									$ 100,755		150,396
Stock issued during period value warrants exercised											$ (47,514)
Purchase Agreement [Member]
Debt instrument redemption price percentage									110.00%
Purchase Agreement [Member] | Beneficiary [Member]
Ownership percentage	4.99%
Shareholders [Member] | Exchange Agreement [Member]
Shares outstanding			9,514,440		8,752,510				9,514,440		8,752,510
Executive [Member] | Warrant [Member]
Convertible notes payable						$ 71,768
Stock issued during period shares new issues						36,463	19,714	8,972	868,098
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			69,062						69,062
Derivative liabilities non current			$ 1,278,786						$ 1,278,786
Fair Value Adjustment of Warrants						$ 77,780
Class of Warrant or Right, Outstanding						52,083
Note Holder [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 4.18						$ 4.18
Placement Agent Warrants [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 2.09						$ 2.09
Series A Preferred Stock [Member]
Preferred stock, shares authorized			20,000		20,000				20,000		20,000
Preferred stock convertible conversion price			$ 0.001		$ 0.001				$ 0.001		$ 0.001
Preferred stock, shares issued			6,304		6,304				6,304		6,304
Preferred stock, shares outstanding			6,304		6,304				6,304		6,304
Preferred stock, liquidation preference			$ 1,000						$ 1,000
Preferred stock dividend rate percentage									12.00%
Debt instrument redemption price percentage									5.00%
Preferred stock convertible conversion price			0.001						$ 0.001
Volume weighted average price percentage									15.00%
Initial conversion price			$ 3.50						$ 3.50
Convertible notes payable			$ 821,500						$ 821,500
Series B Preferred Stock [Member]
Preferred stock, shares authorized			600						600
Preferred stock convertible conversion price	$ 0.001		$ 0.001		$ 0.001				$ 0.001		$ 0.001
Preferred stock, shares issued	220		180						180
Preferred stock, shares outstanding			180						180
Preferred stock convertible purchase price	$ 9,091
Issuance of preferred shares, net	$ 1,900,000		$ 925,000
Debt conversion description									Holders may elect to convert shares of Series B Preferred Stock to common stock at an alternate conversion price equal to 80% (or 70% if the Company’s common stock is suspended from trading on or delisted from a principal trading market or if the Company has effected a reverse split of the common stock) of the lowest daily volume weighed average price of the common stock during the Alternate Conversion Measuring Period (as defined in the Certificate of Designations). In the event the Company receives a conversion notice that elects an alternate conversion price, the Company may, at its option, elect to satisfy its obligation under such conversion with payment in cash in an amount equal to 110% of the conversion amount.
Number of shares convertible securities				40
Preferred shares and dividends shares			25
Convertible notes payable			$ 157,720						$ 157,720
Series B Preferred Stock [Member] | Shares to be Issued [Member]
Preferred stock, shares issued			110						110
Series B Preferred Stock [Member] | Purchase Agreement [Member]
Preferred stock convertible conversion price	$ 10,000
Preferred stock, shares issued	600
Stated value percentage	8.00%
Series B Preferred Stock [Member] | Purchase Agreement [Member] | Beneficiary [Member]
Ownership percentage	19.90%
Series B Preferred Stock [Member] | Purchase Agreement [Member] | Maximum [Member]
Stated value percentage	15.00%